Letermovir for cytomegalovirus prophylaxis in high-risk heart transplant recipients.
Golob S, Batra J, DeFilippis EM, Uriel M, Carey M, Gaine M, Mabasa A, Fried J, Raikelkar J, Restaino S, Hi Lee S, Latif F, Yuzefpolskaya M, Colombo PC, Choe J, Majure D, Jennings D, Pereira MR, Clerkin K, Sayer G, Uriel N.
Golob S, et al. Among authors: batra j.
Clin Transplant. 2022 Dec;36(12):e14808. doi: 10.1111/ctr.14808. Epub 2022 Oct 26.
Clin Transplant. 2022.
PMID: 36086937